Clinical Trial Update: Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

View source ↗

Summary

A completed clinical trial update investigating immunoresponse in patients treated with a tyrosine kinase inhibitor for renal cell carcinoma and gastrointestina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Renal Cell Carcinoma

Snippet

Sponsor: Radboud University Medical Center | Conditions: Renal Cell Carcinoma, GIST | Status: COMPLETED